Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases (2016)
- Authors:
- USP affiliated authors: MORI, ANA LUIZA PEREIRA MOREIRA - FCF ; DOREA, EGIDIO LIMA - HU ; PINTO, GELBA ALMEIDA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- DOI: 10.1590/s1984-82502016000400014
- Subjects: DOENÇAS METABÓLICAS; FARMACOTERAPIA; IDOSOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 2175-9790
- Volume/Número/Paginação/Ano: v. 52, n. 4, p. 699-707, 2016
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MARTINS, Vanessa dos Santos et al. Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases. Brazilian Journal of Pharmaceutical Sciences, v. 52, n. 4, p. 699-707, 2016Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502016000400014. Acesso em: 05 out. 2024. -
APA
Martins, V. dos S., Mori, A. L. P. M., Dórea, E. L., Pinto, G. A., Hirata, M. H., Hirata, F. D. C., & Hirata, R. D. C. (2016). Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases. Brazilian Journal of Pharmaceutical Sciences, 52( 4), 699-707. doi:10.1590/s1984-82502016000400014 -
NLM
Martins V dos S, Mori ALPM, Dórea EL, Pinto GA, Hirata MH, Hirata FDC, Hirata RDC. Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52( 4): 699-707.[citado 2024 out. 05 ] Available from: https://doi.org/10.1590/s1984-82502016000400014 -
Vancouver
Martins V dos S, Mori ALPM, Dórea EL, Pinto GA, Hirata MH, Hirata FDC, Hirata RDC. Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52( 4): 699-707.[citado 2024 out. 05 ] Available from: https://doi.org/10.1590/s1984-82502016000400014 - Métodos de análise de prescrições potencialmente inadequadas para idosos: estudo comparativo
- Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients
- Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Critério de Beers: Avaliação de prescrições para pacientes renais crônicos ambulatoriais
- Impact of cholesterol-lowering therapies on gene expression of adhesion molecules in mononuclear cells from hypercholesterolemic patients
- Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study
- Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
Informações sobre o DOI: 10.1590/s1984-82502016000400014 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas